XML 243 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
Derivative Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Amounts related to cumulative basis adjustments for fair value hedges
At December 31, 2023 and 2022, the following amounts were recorded in the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges:
($ in millions)
At December 31:20232022
Short-term debt
Carrying amount of the hedged item$(1)$(199)
Cumulative hedging adjustments included in the carrying amount—assets/(liabilities)(1)1
Long-term debt
Carrying amount of the hedged item(6,629)(6,216)
Cumulative hedging adjustments included in the carrying amount—assets/(liabilities) (1)
6172
(1)    Includes ($200) million and ($250) million of hedging adjustments on discontinued hedging relationships at December 31, 2023 and 2022, respectively.
Effect of derivative instruments in the Consolidated Income Statement
The total amounts of income and expense line items presented in the Consolidated Income Statement in which the effects of fair value hedges, cash flow hedges, net investment hedges and derivatives not designated as hedging instruments are recorded and the total effect of hedge activity on these income and expense line items are as follows:
($ in millions)
TotalGains/(Losses) of
Total Hedge Activity
For the year ended December 31:202320222021202320222021
Cost of services$21,051 $21,062 $19,147 $(5)$24 $43 
Cost of sales6,127 6,374 6,184 22 99 (16)
Cost of financing382 406 534 (11)
SG&A expense19,003 18,609 18,745 165 (211)176 
Other (income) and expense(914)5,803 873 17 (225)(205)
Interest expense1,607 1,216 1,155 (54)
($ in millions)
Gain/(Loss) Recognized in Consolidated Income Statement
Consolidated
Income Statement
Line Item
Recognized on
Derivatives
Attributable to Risk
Being Hedged(2)
For the year ended December 31:202320222021202320222021
Derivative instruments in fair value hedges (1)
       
Interest rate contractsCost of
financing
$(17)$(73)$(1)$(2)$85 $18 
Interest
expense
(83)(257)(2)(11)299 53 
Derivative instruments not designated as hedging instruments
Foreign exchange contractsOther (income)
and expense
(192)(492)(48)N/AN/A N/A
Equity contractsSG&A expense153 (249)201 N/AN/A N/A
Other (income)
and expense
— (83)— N/AN/A N/A
Total $(140)$(1,153)$150 $(13)$384 $71 
($ in millions)
Gain/(Loss) Recognized in Consolidated Income Statement and Other Comprehensive Income
For the year ended Recognized in OCI Consolidated
Income Statement
Line Item
Reclassified
from AOCI
Amounts Excluded from
Effectiveness Testing (3)
December 31:202320222021202320222021202320222021
Derivative instruments in cash flow hedges       
Interest rate contracts$— $— $— Cost of financing$(3)$(4)$(4)$— $— $— 
Interest
expense
(15)(14)(13)— — — 
Foreign exchange contractsCost of services(5)24 43 — — — 
Amount included in the assessment of effectiveness213 241 344 Cost of sales22 99 (16)— — — 
Amount excluded from the assessment of effectiveness(6)— — Cost of financing(11)(21)(18)— — — 
SG&A expense12 38 (24)— — — 
Other (income) and expense
239 349 (157)(29)— — 
Interest
expense
(51)(72)(52)— — — 
Instruments in net investment hedges (4)
 
Foreign exchange contracts(397)1,613 1,644 Cost of financing— — — 22 14 
Interest
expense
— — — 105 50 17 
Total$(190)$1,854 $1,989  $189 $400 $(243)$98 $64 $23 
(1)    The amount includes changes in clean fair values of the derivative instruments in fair value hedging relationships and the periodic accrual for coupon payments required under these derivative contracts.
(2)    The amount includes basis adjustments to the carrying value of the hedged item recorded during the period and amortization of basis adjustments recorded on de-designated hedging relationships during the period.
(3)    The company’s policy is to recognize all fair value changes in amounts excluded from effectiveness testing in net income each period.
(4)    Instruments in net investment hedges include derivative and non-derivative instruments with the amounts recognized in OCI providing an offset to the translation of foreign subsidiaries.
N/A–Not applicable